On Wednesday, February 5, 2020 LifeSciences BC held its 5th annual ACCESS TO INNOVATION Conference at the Vancouver Convention Centre West.

Theme: “Innovation adoption – accelerating patient outcomes”

Stakeholders included: Academia, Health Institutions, Government, Centres of Innovation, SMEs, Multi-national Corporations, Investors and Payers.

Access to Innovation AGENDA

Speakers: 

• Ali Ardakani, Vice Chair – LifeSciences BC Board of Directors, Founder & Managing Partner – Novateur Ventures Inc. 
• Dr. Stirling Bryan, President – BC Academic Health Science Network 
• Dr. Bethany Edmunds, Associate Dean – Northeastern University Vancouver Campus 
• Dr. Fabio Feldman, Director, Clinical Quality & Patient Safety – Fraser Health Authority 
• Dr. Alexandra T. Greenhill, CEO & Chief Medical Officer – Careteam Technologies Inc. 
• Dr. Ehsan Karim, Scientist & Biostatistician – CHÉOS 
• Colleen Kennedy, Executive Director, Health System Improvement & Engagement – BC Patient Safety & Quality Council 
• Handol Kim, Co-Founder & CEO – Variational AI, Vice Chair – AInBC 
• Dr. Darryl Knight, VP, Research & Academic Affairs – Providence Health Care 
• Margaret Lau, Senior Manager and Leader, Health Care and Life Sciences, British Columbia – Deloitte 
• Dr. Howard Lim, Medical Oncologist – BC Cancer, Clinical Associate Professor of Medicine – UBC 
• Vince Lozada, Managing Director, Biotechnology Investment Banking – RBC Capital Markets, San Francisco 
• Dr. Elicia Maine, Professor, Technology and Operations Management – Simon Fraser University 
• Dr. Malcolm Moore, Past President – BC Cancer Agency 
• W. Neil Palmer, Senior Strategic Advisor & President Emeritus – PDCI Market Access Inc. 
• Scott Phillips, President & CEO – StarFish Medical, Chair – LifeSciences BC Board of Directors 
• Dr. David Poon, VP Business Development and Alliance Management – Zymeworks 
• Dr. Rachael Ritchie, Director of Innovation – Vancouver Coastal Health 
• Dr. Maryam Sadeghi, CEO – MetaOptima 
• Dr. Don Sin, Professor – UBC Department of Medicine 
• Michelle Theroux, Leader, Health Strategy & Innovation and National Leader, Smart Health Communities – Deloitte 
• Dr. Brad Thomas, Diagnostic Liaison – Oncology, Western Canada – AstraZeneca 
• Dr. Lisa Toltl, Director, Medical Affairs Oncology & Cell Therapy – Kite, a Gilead Company 
• Dick Vollet, President & CEO – St. Paul’s Hospital Foundation 
• Dr. Alan Winter, Past BC Innovation Commissioner and Former President – Genome BC 
• Dr. Stephen Yip, Interim Medical Director – BC Cancer Agency

Moderators:

• Dr. Bev Holmes, President & CEO – Michael Smith Foundation for Health Research
• Steve Lowry, Executive Director – AInBC 
• Dr. Simon Pimstone, CEO – Xenon Pharmaceuticals Inc. 
• Dr. Pascal Spothelfer, President & CEO – Genome BC 

Thank you to our sponsors!

_{Lunch Sponsor}

_{Session Sponsors}

                              

_{Keynote Sponsor}

_{Technology Sponsor}

_{Breakfast Sponsor}

_{Break Sponsors} 

_{Event Supporter}

_Exhibitor